NANCY J ZIDEK

Allopathic & Osteopathic Physicians|Family Medicine HOLTON, KS NPI 1528048063

General Payments — all program years on this page

$2,079.49

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 131
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $261.09 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $261.0916

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $252.3619
2019 $333.8418
2020 $388.0425
2021 $314.1922
2022 $252.8815
2023 $277.0916
2024 $261.0916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087399194 Novartis Pharmaceuticals Corporation $20.45 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092579421 Boston Scientific Corporation $19.63 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097302060 Novo Nordisk Inc $13.68 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097441365 Novo Nordisk Inc $13.83 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097483463 Novo Nordisk Inc $14.19 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105562362 AstraZeneca Pharmaceuticals LP $15.91 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106397667 ABBVIE INC. $19.47 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117725923 Amgen Inc. $16.92 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118044454 Boehringer Ingelheim Pharmaceuticals, Inc. $14.19 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135232893 Lilly USA, LLC $16.16 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135268084 Lilly USA, LLC $23.21 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137703016 Takeda Pharmaceuticals U.S.A., Inc. $14.76 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145984413 Lundbeck LLC $13.23 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148939654 Sumitomo Pharma America, Inc. $14.57 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148939656 Sumitomo Pharma America, Inc. $14.29 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153591974 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.60 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.